Capstone Development Solutions partners with the world’s premier healthcare companies to support their goal of bringing more new products to market, quickly and efficiently. The company leads development, manages regulatory services and achieves timely approval of pharmaceutical and medical device products on its clients' behalf. Water Street established Capstone in 2013 as a new way to support healthcare companies with expanding their product development portfolios without increasing their operating expenses. It is one of the few strategic investment firms to offer this unique solution. Dan Robins, PhD, who has more than 25 years of research and development experience, leads the company’s team of scientists and regulatory experts. Al Heller, former CEO of American Pharmaceutical Partners (APPI), serves as Capstone's chairman.

Subscribe to Water Street News

To receive Water Street news via email,
please complete the form below.

Privacy Policy

You’ve just been sent an email to confirm your email address. Please click on the link in the email to activate your subscription.

If you do not receive an email from us within a few minutes, please check your spam folder. If our email did not come through to you, please click on this link,

Something went wrong. If you are seeing this error, please let us know, and we will get it fixed asap.